SARS-CoV-2: Mikrobiyology and Epidemiology
PDF
Cite
Share
Request
Review
VOLUME: 30 ISSUE: 60
P: 27 - 35
2020

SARS-CoV-2: Mikrobiyology and Epidemiology

Anatol J Gen Med Res 2020;30(60):27-35
1. University of Helth Sciences,Izmir Tepecik Education and Research Hospital, Department of Infectious Diseases and Clinical Microbiology, Izmir, Turkey
No information available.
No information available
Received Date: 2020-05-08T14:52:10
Accepted Date: 2020-07-09T14:48:16
PDF
Cite
Share
Request

Abstract

In December 2019, a novel coronavirus infection emerged in Wuhan, China and spread 215 countries throughout worldwide within few months. It has already infected more than 3700000 people and caused more than 250000 deaths globally. This has been the third coronavirus that cause acute severe respiratory infections, following severe acute respiratory syndrome (SARS) in 2003 and Middle East respiratory syndrome in 2012. The World Health Organization named the disease “COVID‐19” and announced the COVID‐19 pandemi on 12 March 2020. Coronaviruses are RNA viruses with the largest known genome. In replication of RNA viruses, mutation rates are considered to be much higher than DNA viruses. As the amount of copies they replicate increases, they are more likely to make mistakes, resulting in the development of a new mutation, infection of new cell types.

Keywords:
COVID-19, epidemiology, pandemic